COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - share repurchase programme
26/10/2026
Bagsværd, Denmark, 26 October 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Erdem Hospital Wins Two GIGI Awards for World Cup Connected TV Campaign
26/10/2026
Erdem Hospital’s international advertising campaign used live 2026 FIFA World Cup match data to deliver real-time, local-language messages across key European markets, earning two awards at the 16th GIGI Awards ISTANBUL [...]
Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support
26/10/2026
Two2Ten Foundation supports the continued development of Seek Labs’ Sequence Ablation Therapeutics (SAT) platform into oncology, honoring the memory of Travis Snyder SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- [...]
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
26/10/2026
More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider care NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE [...]
CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance
26/10/2026
- Collaboration will combine CasZyme’s Cas12l nuclease with Cirena’s RNA manufacturing excellence to optimise editing efficiency - Output of the collaboration could prove highly relevant in CAR-T and LNP-based [...]
Newsweek Places KFSH in Top 4% of World’s Smart Hospitals for Digital Maturity and AI
26/10/2026
RIYADH, Saudi Arabia, Oct. 26, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) is one of only 15 hospitals worldwide to receive both the maximum five-ribbon digital maturity rating [...]
Kraig Labs Moves Beyond Bold Breakthrough
26/10/2026
DENVER, Oct. 26, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) — Kraig Biocraft Laboratories (OTCQB: KBLB) is moving beyond the science of spider silk and into the business of making it matter. For years, commercial [...]
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
26/10/2026
REDWOOD CITY, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its third quarter 2026 financial results will be released on Monday, November 9, 2026. Starting at 5: [...]
Transactions under Novonesis’ share buyback program
26/10/2026
Please read the announcement in PDF Attachment 2026_25_Share_buyback
U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week
26/10/2026
Vadadustat demonstrated a clinically meaningful safety outcome benefit in U.S. patients with anemia due to CKD on dialysis utilizing TIW dosing regimen WALTHAM, Mass., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Akebia [...]
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
26/10/2026
Health Uncensored with Dr. Drew spotlights ambitious international trial plans, a novel delivery approach and the patient experiences driving NeOnc’s research DENVER, Oct. 26, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews. [...]
Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
26/10/2026
Important Secondary Clinical Outcome Endpoint MACE Achieved Statistical Significance ELPIS II 2 Data in HLHS Selected for Late-Breaking Science Program Podium Presentation in the American Heart Association’s (AHA) 2026 [...]
X9 Receives FDA Breakthrough Device Designation for Investigational Dialysis Cannulation System and Completes Second Clinical Study
26/10/2026
ACCESS-2 study provides additional clinical experience with X9's investigational technology for vascular access in hemodialysis WALLINGFORD, Conn., Oct. 26, 2026 (GLOBE NEWSWIRE) -- X9, Inc., a privately held medical [...]
Major shareholder announcement
26/10/2026
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis has received a major shareholder notification from BlackRock, Inc. regarding its holdings in Novonesis. As of October 22, 2026, BlackRock, Inc.’s [...]
SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies
26/10/2026
UC Davis is the primary manufacturing site for CER-1236, site activation is expected to expand patient recruitment capacity and streamline treatment logistics Update follows SRX’s previously announced definitive [...]
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
26/10/2026
CERRITOS, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (“STLN”) (NASDAQ: STLN) a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2026 [...]
More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds
26/10/2026
Early findings presented at ASHG 2026 indicate nearly all people choose to learn their genetic health risks when given the option PALO ALTO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- New research from 23andMe Research [...]
Imprivata Recognized for the First Time in the Gartner® Magic Quadrant™ for Privileged Access Management
26/10/2026
Imprivata combines privileged, agentic AI, and third-party access management into a single comprehensive platform to help organizations reduce risk, meet regulatory compliance requirements, and improve operational [...]
Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers
26/10/2026
Durability of faridoxorubicin (AVA6000) activity results from the continued release of doxorubicin by fibroblast activation protein (FAP) demonstrated beyond 10 cycles of therapy FAPI-PET imaging data indicate prolonged [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum